DBV Technologies (DBVT) EBIT (2020 - 2026)
DBV Technologies (DBVT) reported EBIT of -$47.9 million for Q1 2026, down 80.08% year-over-year from -$240.4 million in Q1 2025, and down 6.32% quarter-over-quarter from -$45.1 million in Q4 2025.
DBV Technologies (DBVT) EBIT (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of EBIT data on file, last reported at -$47.9 million in Q1 2026.
- EBIT for Q1 2026 came in at -$47.9 million, down 80.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$168.3 million (down 46.85% YoY), and the FY2025 annual result was -$147.1 million, down 26.13% from the prior year.
- EBIT fell to -$47.9 million in Q1 2026 per DBVT's latest filing, from -$45.1 million in the prior quarter.
- Over five years, EBIT peaked at -$11.9 million in Q4 2023 and troughed at -$47.9 million in Q1 2026.
- A 5-year average of -$28.5 million and a median of -$26.6 million in 2025 frame the typical range for EBIT.
- The sharpest annual moves came in 2022 and 2023: EBIT slumped 182.09% in 2022, then soared 68.65% in 2023.
- A 5-year view of EBIT shows it stood at -$38.0 million in 2022, then jumped by 68.65% to -$11.9 million in 2023, then tumbled by 100.18% to -$23.9 million in 2024, then sank by 88.81% to -$45.1 million in 2025, then fell by 6.32% to -$47.9 million in 2026.
- Business Quant data shows DBVT's EBIT at -$47.9 million in Q1 2026, -$45.1 million in Q4 2025, and -$34.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -47.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.90 Mn |
| Dec 31, 2025 | -45.05 Mn |
| Sep 30, 2025 | -34.28 Mn |
| Jun 30, 2025 | -41.11 Mn |
| Mar 31, 2025 | -26.60 Mn |
| Dec 31, 2024 | -23.86 Mn |
| Sep 30, 2024 | -30.33 Mn |
| Jun 30, 2024 | -33.84 Mn |
| Mar 31, 2024 | -28.56 Mn |
| Dec 31, 2023 | -11.92 Mn |
| Sep 30, 2023 | -18.27 Mn |
| Jun 30, 2023 | -25.08 Mn |
| Mar 31, 2023 | -21.17 Mn |
| Dec 31, 2022 | -38.02 Mn |
| Sep 30, 2022 | -18.02 Mn |
| Jun 30, 2022 | -23.82 Mn |
| Mar 31, 2022 | -16.77 Mn |
| Dec 31, 2021 | -13.48 Mn |
| Sep 30, 2021 | -24.37 Mn |
| Jun 30, 2021 | -31.13 Mn |